image:Editor-in-Chief of Mucosal Immunology view more

Credit: Ben Marsland

Amsterdam, July 18, 2022 The Society for Mucosal Immunology (SMI), the preeminent international community of researchers working together to advance the field of mucosal immunology and improve health worldwide, and Elsevier, a global leader in research publishing and information analytics, are delighted to announce a new partnership to publish SMIs official journal, Mucosal Immunology. The journal will transition to gold open access, making articles immediately and permanently available for everyone to read, download, copy and distribute. It will be hosted on Elseviers leading online platform, ScienceDirect, beginning January 2023.

SMIs decision to partner with Elsevier furthers its ongoing mission to directly support research and education and foster communication and collaboration in the field of mucosal immunology. Transitioning its journal from its current subscription model to gold open access clearly reflects its commitment to make its content more easily accessible and drive innovation in the field.

SMI President Michael McGuckin, PhD, said: We welcome Elsevier as our new publisher and look forward to taking advantage of its publishing expertise and commitment to open science as we continue our journey to increase the visibility and influence of Mucosal Immunology together. It is clear from our early interactions with Elsevier staff and leadership that this will be a partnership in the truest sense of the word and enable us to build upon the journals high standards and further enhance its global prominence.

Since 1990, mucosal immunology has expanded from what many considered a niche discipline to one of the hottest areas in immunobiology today, underpinned by interactions with the microbiome and nervous system that have profound implications for health and disease. The journal fosters cross-fertilization between scientists, clinical researchers and industry professionals across a broad spectrum of specialties working on pathways of immunity and inflammation at barrier surfaces. They rely on Mucosal Immunology for the very latest robust, cutting-edge original research and reviews in basic, translational and clinical science.

The journal has earned a strong reputation for publishing papers based on the quality of the science, its rapid and rigorous peer review, and its contributions to advancing the field. This is demonstrated by its impressive 2021 Journal Impact Factor of 8.701* and a steadily increasing online and social media community.

Mucosal Immunologys eminent international editorial board under the continued leadership of Editor-in-Chief Ben Marsland, PhD, ensures that this high quality, peer-reviewed journal will continue to be an authoritative resource for the community it serves.

The editorial board and I are tremendously excited for the opportunity to partner with Elsevier to publish Mucosal Immunology, said Professor. Marsland. I have every confidence that support from the Elsevier team will foster even greater success in our ongoing efforts to publish novel, transformative, and clinically relevant science. On behalf of Mucosal Immunologys editors, editorial staff, reviewers, and authors, I want to welcome our new partner.

Elsevier is firmly committed to the continuity of the journals rigorous editorial process and accessibility of content, and further solidifying Mucosal Immunologys reputation.

We are delighted that SMI has selected Elsevier as its publishing partner. By combining their expertise with Elseviers industry-leading resources for authors, editors, peer reviewers and readers, we will ensure the best possible support for SMIs mission and community. By working together, we can achieve a more inclusive, collaborative and transparent world of research, stated Louise Curtis, Senior Vice President, Life Sciences & Social Sciences, at Elsevier.

Mucosal Immunology is a great asset to the Elsevier immunology journal portfolio, and we look forward to helping the society and their journal navigate a successful transition to full open access status, added Jenny Henzen, Elseviers Publisher for Immunology.

*Journal Citation Reports, Clarivate, 2022

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read more here:
Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology - EurekAlert